相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A commentary on the differences in pharmacokinetics between recombinant and plasma-derived factor IX and their implications for dosing
S. Bjorkman
HAEMOPHILIA (2011)
PEGylation of therapeutic proteins
Simona Jevsevar et al.
BIOTECHNOLOGY JOURNAL (2010)
Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study
P. Collins et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Recombinant Factor IX for Clinical and Research Use
Paul E. Monahan et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Future directions in hemostasis: Normalizing the lives of patients with hemophilia
Marcus E. Carr
THROMBOSIS RESEARCH (2010)
Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience
C. E. Neunert et al.
HAEMOPHILIA (2008)
The pharmacology of PEGylation: Balancing PD with PK to generate novel therapeutics
C. Simone Fishburn
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Extending half-life in coagulation factors: where do we stand?
David Lillicrap
THROMBOSIS RESEARCH (2008)
Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV
Sarah C. Darby et al.
BLOOD (2007)
Reformulated BeneFix®:: efficacy and safety in previously treated patients with moderately severe to severe haemophilia B
T. Lambert et al.
HAEMOPHILIA (2007)
Recombinant factor VIIa (eptacog alfa) - A pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX
Katherine A. Lyseng-Williamson et al.
PHARMACOECONOMICS (2007)
Considerations in the evaluation of haemophilia patients for short-term prophylactic therapy: a paediatric and adult case study
L Luchtman-Jones et al.
HAEMOPHILIA (2006)
Practice patterns in haemophilia A therapy - global progress towards optimal care
S Geraghty et al.
HAEMOPHILIA (2006)
Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia
AD Shapiro et al.
HAEMOPHILIA (2005)
The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B
AD Shapiro et al.
BLOOD (2005)
Health status and health-related quality of life of children with haemophilia from six West European countries
A Gringeri et al.
HAEMOPHILIA (2004)
The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation
PHB Bolton-Maggs et al.
HAEMOPHILIA (2004)
Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspective
S Björkman
HAEMOPHILIA (2003)
Prophylaxis in factor IX deficiency product and patient variation
CT Kisker et al.
HAEMOPHILIA (2003)
Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome
K Fischer et al.
HAEMOPHILIA (2002)
Pharmacokinetic analysis of plasma-derived and recombinant FIX concentrates in previously treated patients with moderate or severe hemophilia B
BM Ewenstein et al.
TRANSFUSION (2002)
Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
DA Roth et al.
BLOOD (2001)
Catheter-related deep venous thrombosis in children with hemophilia
JM Journeycake et al.
BLOOD (2001)
Pharmacokinetics of recombinant factor IX in relation to age of the patient:: implications for dosing in prophylaxis
S Björkman et al.
HAEMOPHILIA (2001)
分享论文
